Literature DB >> 29017843

Short-term reasons for withdrawal and adverse events associated with apremilast therapy for psoriasis in real-world practice compared with in clinical trials: A multicenter retrospective study.

Arvin Ighani1, Jorge R Georgakopoulos2, Neil H Shear3, Scott Walsh3, Jensen Yeung4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29017843     DOI: 10.1016/j.jaad.2017.09.067

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  4 in total

1.  Effectiveness and clinical predictors of drug survival in psoriasis patients receiving apremilast: A registry analysis.

Authors:  Thomas Graier; Wolfgang Weger; Paul-Gunther Sator; Wolfgang Salmhofer; Barbara Gruber; Constanze Jonak; Claudia Kölli; Martina Schütz-Bergmayr; Igor Vujic; Gudrun Ratzinger; Nina Häring; Clemens Painsi; Knut Prillinger; Alexander Mlynek; Hans Skvara; Hannes Trattner; Adrian Tanew; Roland Lichem; Christina Ellersdorfer; Franz Legat; Alexandra Gruber-Wackernagel; Angelika Hofer; Erich Schmiedberger; Wolfram Hoetzenecker; Robert Müllegger; Werner Saxinger; Franz Quehenberger; Peter Wolf
Journal:  JAAD Int       Date:  2020-12-26

Review 2.  Long-term Safety of Oral Systemic Therapies for Psoriasis: A Comprehensive Review of the Literature.

Authors:  Deepak M W Balak; Sascha Gerdes; Aurora Parodi; Laura Salgado-Boquete
Journal:  Dermatol Ther (Heidelb)       Date:  2020-06-11

3.  Clinical efficacy, speed of improvement and safety of apremilast for the treatment of adult Psoriasis during COVID-19 pandemic.

Authors:  Daniele Melis; Cristina Mugheddu; Silvia Sanna; Laura Atzori; Franco Rongioletti
Journal:  Dermatol Ther       Date:  2020-06-24       Impact factor: 3.858

4.  Apremilast in Refractory Behçet's Syndrome: A Multicenter Observational Study.

Authors:  Matheus Vieira; Solène Buffier; Mathieu Vautier; Alexandre Le Joncour; Yvan Jamilloux; Mathieu Gerfaud-Valentin; Laurence Bouillet; Estibaliz Lazaro; Stéphane Barete; Laurent Misery; Delphine Gobert; Tiphaine Goulenok; Olivier Fain; Karim Sacre; Pascal Sève; Patrice Cacoub; Cloé Comarmond; David Saadoun
Journal:  Front Immunol       Date:  2021-02-04       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.